Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum

NCT00909987 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Rectum Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Bevacizumab
RADIATION: Radiotherapy
DRUG: Capecitabine during all Radiotherapy period
PROCEDURE: Total Mesorectal Excision (TME)

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo

Collaborators

[object Object]